A biopharmaceutical company developing novel therapies for rare neurological and genetic disorders, including enzyme replacement therapy for Sanfilippo Syndrome Type B and treatments for depression and congenital adrenal hyperplasia.
South San Francisco, CA, United States~8 employeesFounded Jan 2014Website